UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041761
Receipt number R000047655
Scientific Title Inspection of the safety of OS-1 jelly intake in people with dysphagy
Date of disclosure of the study information 2021/03/01
Last modified on 2023/03/16 14:38:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Inspection of the safety of OS-1 jelly
intake in people with dysphagy

Acronym

Inspection of the safety of OS-1 jelly
intake in people with dysphagy

Scientific Title

Inspection of the safety of OS-1 jelly
intake in people with dysphagy

Scientific Title:Acronym

Inspection of the safety of OS-1 jelly
intake in people with dysphagy

Region

Japan


Condition

Condition

People with suspected dysphagia

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the safety of OS-1 jelly intake
in patients with dysphagia.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Ingestion availability

Key secondary outcomes

Number of swallows
Time to induce swallowing reflex
Position of bolus at the start of swallowing reflex
Presence or absence of bolus residue
Pharyngeal residue
Penetration Aspiration Scale


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

1.drink 5cc OS-1 3 times.
2.drink 5cc OS-1 jelly 3 times.
3.drink 5cc middle thickened water 3 times.

Interventions/Control_2

1.drink 5cc OS-1 3 times.
2.drink 5cc OS-1 jelly 3 times.
3.drink 5cc middle thickened water 3 times.

Interventions/Control_3

1.drink 5cc OS-1 3 times.
2.drink 5cc OS-1 jelly 3 times.
3.drink 5cc middle thickened water 3 times.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patient with dysphagia suspected
Those who have received sufficient explanation before participating in this study and
who have agreed to participate in the study.

Key exclusion criteria

Those who cannot perform videoendoscopic
examination of swallowing
Those who are in poor general condition and
are considered to have a significantly high risk of aspiration

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kazuharu
Middle name
Last name Nakagawa

Organization

Graduate School of Medical and Dental
Sciences,Tokyo Medical and Dental University

Division name

Depertment of Dysphagia rehabiritation

Zip code

1138510

Address

1-5-45, Yushima, Bunkyo, Tokyo 113-8510, Japan

TEL

0358034560

Email

nakagerd@tmd.ac.jp


Public contact

Name of contact person

1st name Kanako
Middle name
Last name Yoshimi

Organization

Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

Division name

Depertment of Dysphagia rehabiritation

Zip code

1138510

Address

1-5-45, Yushima, Bunkyo, Tokyo 113-8510, Japan

TEL

0358035562

Homepage URL


Email

k.yoshimi.gerd@tmd.ac.jp


Sponsor or person

Institute

Graduate School of Medical and Dental
Sciences, Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Factory, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

Address

1-5-45, Yushima, Bunkyo, Tokyo 113-8510, Japan

Tel

0358035562

Email

k.yoshimi.gerd@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 01 Day


Related information

URL releasing protocol

https://www.dovepress.com/articles.php?article_id=82114

Publication of results

Published


Result

URL related to results and publications

https://www.dovepress.com/articles.php?article_id=82114

Number of participants that the trial has enrolled

36

Results

The time until the swallowing reflex was induced and the position of the swallowing reflex triggered were significantly earlier for ORS jelly (p=0.012, p=0.001). The incidence of pharyngeal residue was significantly lower with ORS jelly (p=0.002). The Penetration-Aspiration Scale score was similar for both samples (p=0.062), and no aspiration was observed in either sample.

Results date posted

2023 Year 03 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

36 patients diagnosed with dysphagia based on videoendoscopic evaluation (VE). They received visiting or outpatient care at our university hospital between February and December 2021 and who required VE. Assigned dentists explained the study to their patients when performing the VE and recruited participants. The inclusion

Participant flow

Assigned dentists explained the study to their patients when performing the VE and recruited participants.

Adverse events

None

Outcome measures

Age, sex, primary disease of dysphagia, and Dysphagia Severity Scale (DSS),and Functional Oral Intake Scale (FOIS) scores were extracted from their medical records.
Outcome measures: number of swallows, time until the swallowing reflex was induced, position of the bolus that triggered the swallowing reflex, pharyngeal residue in the vallecula and pyriform sinuses, Penetration-Aspiration scale

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 10 Month 01 Day

Date of IRB

2021 Year 02 Month 08 Day

Anticipated trial start date

2020 Year 10 Month 19 Day

Last follow-up date

2021 Year 12 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 09 Month 11 Day

Last modified on

2023 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047655